Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Advocacy for clinical trials: do the Royal Colleges and State cancer councils play an appropriate role?
Autore:
Ellis, PM; Tattersall, MHN;
Indirizzi:
Hamilton Reg Canc Ctr, Hamilton, ON L8V 1C3, Canada Hamilton Reg Canc CtrHamilton ON Canada L8V 1C3 lton, ON L8V 1C3, Canada Univ Sydney, Dept Canc Med, Sydney, NSW 2006, Australia Univ Sydney Sydney NSW Australia 2006 nc Med, Sydney, NSW 2006, Australia
Titolo Testata:
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
fascicolo: 1, volume: 25, anno: 2001,
pagine: 9 - 11
SICI:
1326-0200(200102)25:1<9:AFCTDT>2.0.ZU;2-6
Fonte:
ISI
Lingua:
ENG
Soggetto:
ATTITUDES; ETHICS;
Tipo documento:
Editorial Material
Natura:
Periodico
Settore Disciplinare:
Social & Behavioral Sciences
Citazioni:
11
Recensione:
Indirizzi per estratti:
Indirizzo: Ellis, PM Hamilton Reg Canc Ctr, 699 Concess St, Hamilton, ON L8V 1C3, Canada Hamilton Reg Canc Ctr 699 Concess St Hamilton ON Canada L8V 1C3
Citazione:
P.M. Ellis e M.H.N. Tattersall, "Advocacy for clinical trials: do the Royal Colleges and State cancer councils play an appropriate role?", AUS NZ J PU, 25(1), 2001, pp. 9-11

Abstract

Background: Endorsement of clinical trials by prominent local or national organisations may help to promote public awareness of and enhance patient and doctor participation in randomised trials. Method: A survey was undertaken of the specialist medical colleges of Australia, State and Territory cancer councils and national cancer organisations, inquiring about their formal position on patient participation in randomised clinical trials and any activities they undertake to promote clinical trial participation. Results: Responses were received from 18 of 20 organisations surveyed. Themajority (13/18) support the idea that patients should be invited to participate in well-designed clinical trials. Only 9/18 organisations have any formal policy encouraging clinical trial participation and only five undertake any activity to promote clinical trials. These activities relate more tofacilitating clinician participation through affiliation with cooperative oncology groups/clinical trial organisations and provision of funds for data management. Only two organisations are proactive in promoting trials to clinicians and patients. Conclusion: Promoting/endorsing clinical trial participation is a priorityarea identified in the national cancer control plan and implementation strategy. Prominent organisations such as specialist medical colleges and State cancer councils should explore ways in which they can act as advocates topromote clinical trial participation.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/20 alle ore 00:44:35